GNRH1 and endometriosis: Recent literature has shown that GnRH antagonists have resulted in oral drugs (Elagolix has been approved by the FDA, Linzagolix and Relugolix are undergoing clinical trials), which have fewer side effects than other therapies and are a welcome addition in the treatment of endometriosis-associated pain [4].